作者
David S. Ettinger,Douglas E. Wood,Dara L. Aisner,Wallace Akerley,Jessica R. Bauman,Ankit Bharat,Débora S. Bruno,Joe Y. Chang,Lucian R. Chirieac,Thomas A. D’Amico,Thomas J. Dilling,Jonathan E. Dowell,Scott Gettinger,Matthew A. Gubens,Aparna Hegde,Mark Hennon,Rudy P. Lackner,Michael Lanuti,Ticiana Leal,Jules Lin,Billy W. Loo,Christine M. Lovly,Renato Martins,Erminia Massarelli,Daniel Morgensztern,Thomas Ng,Gregory A. Otterson,Sandip Pravin Patel,Gregory J. Riely,Steven E. Schild,Theresa A. Shapiro,Aditi P. Singh,James Stevenson,Alda L. Tam,Jane Yanagawa,Stephen C. Yang,Kristina M. Gregory,Miranda Hughes
摘要
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines regarding targeted therapies, immunotherapies, and their respective biomarkers.